Practice treatment guidelines should summarize the best evidence.   Unfortunately the 2000 and 2006 Infectious Disease guidelines did not reflect Evidence Based Medicine.   This resulted in the Connecticut Attorney General having to launch an antitrust investigation into the IDSA guidelines because of important commercial conflicts of interest and suppression of scientific evidence that had tainted the guideline process.   International Lyme and Associated Diseases Society (ILADS)  guidelines have passed the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system with a higher rating than the CDC and IDSA guidelines so it would seem prudent to follow their higher standards of care.   The CDC lab has been shown repeatedly to have lax standards of security so whose labs are the tainted ones?

Labels: moderation: safe